#biocon
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garage
Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who built the company from a garage into a global biotech leader, Kiran is ensuring continuity by handing over to a science-d…
Biocon's Mazumdar-Shaw sets out 5-year succession plan, names niece Claire as successor
Before founding Bicara, Claire led business development and corporate strategy at Rheos Medicines and worked at Third Rock Ventures, where she focused on company formation and partnerships
Biocon’s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: Report
Biocon founder Kiran Mazumdar-Shaw has announced her successor. Niece Claire Mazumdar will lead the company. Claire Mazumdar is the founder and CEO of Bicara Therapeutics. She holds advanced degrees and has prior industry experience. Biocon is also undergoing…
Why Sun Pharma’s massive Organon buyout is winning over investors where Lupin, Biocon failed
Sun Pharma’s acquisition of Organon marks a pivot toward biosimilars, utilizing a cheap valuation and strong cash reserves to avoid the chronic post-merger stock slumps seen by Indian rivals.